• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

GlaxoSmithKline Pharmaceuticals Ltd

+ Add to Watchlist


3,343.05 INR 189.05 5.99%

As of 06:05:58 ET on 01/23/2015.

Snapshot for GlaxoSmithKline Pharmaceuticals Ltd (GLXO)

Open: 3,150.00 Day's Range: 3,140.00 - 3,525.00 Volume: 172,895
Previous Close: 3,154.00 52wk Range: 2,351.60 - 3,525.00 1-Yr Rtn: +14.25%

Stock Chart for GLXO

No chart data available.
  • GLXO:IN 3,343.05
  • 1D
  • 1M
  • 1Y
Interactive GLXO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GLXO

Current P/E Ratio (ttm) 58.7841
Estimated P/E(12/2014) 59.8319
Relative P/E vs. SENSEX 2.8918
Earnings Per Share (INR) (ttm) 56.8700
Est. EPS (INR) (12/2014) 55.8740
Est. PEG Ratio 149.5799
Market Cap (M INR) 283,166.41
Shares Outstanding (M) 84.70
30 Day Average Volume 21,027
Price/Book (mrq) 14.2314
Price/Sale (ttm) 11.1556
Dividend Indicated Gross Yield 1.50%
Cash Dividend (INR) 50.0000
Dividend Ex-Date 04/03/2014
5 Year Dividend Growth 17.84%
Next Earnings Announcement 02/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GLXO

No data available

Company Profile & Key Executives for GLXO

Glaxosmithkline Pharmaceuticals Ltd. manufactures and distributes a wide variety of pharmaceutical drugs, veterinary products and laboratory chemicals. The Company's products include "Phexin" capsules, "Betnesol" tablets and injections, "Becoride" asthma treatment, "Betnovate" ointment, "Cetzine" antihistamine, "Zucox" and "Rizap" anti-tuberculosis products.

H B JoshipuraManaging DirectorAndrew AristidouCFO/Executive Director
H BuchExec VP:PharmaceuticalsS KhannaVP:Finance
More Company Profile & Key Executives for GLXO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil